Obesity in England has reached unprecedented levels, with the proportion of adults classified as obese doubling over the past three decades. According to analysis by the King’s Fund, rates stood at 15% in 1993 and climbed to 30% in 2024. This trajectory translates to approximately 7 million additional adults living with obesity compared to rates remaining at 1993 levels. Currently, 14 million adults in England are classified as obese.
Young adults have experienced the most dramatic increases. Among those aged 16 to 24, obesity or severe obesity rates jumped from 6% in 1993 to 18% in 2024. This represents approximately one million young adults living with obesity, or 700,000 more than would be the case if rates had remained stable over the past three decades. Public health experts characterize this trend as a significant concern.
Multiple structural and economic factors have contributed to rising obesity. The shift from manual labor-intensive manufacturing jobs to sedentary office positions has reduced physical activity among working populations. Food affordability has declined, driven by increased supermarket competition and the proliferation of fast food outlets and delivery services. High-fat, high-salt, and high-sugar foods are now cheaper and more accessible than they were in the 1990s. Areas experiencing economic deprivation face particular challenges, as less healthy foods are disproportionately available and affordable in these regions.
Obesity carries significant health risks, serving as a risk factor for type 2 diabetes, heart disease, high blood pressure, osteoarthritis, and certain cancers. The economic impact is substantial, with obesity and being overweight estimated to cost the UK economy approximately £126 billion annually, including £12 billion to the NHS.
Governments have pursued various policy responses over the past three decades. Recent interventions include a jab and television advertising ban implemented by the Labour government in January this year, restrictions considered under previous administrations, and a 2018 soft drink levy that prompted manufacturers to reduce sugar content. Weight loss medications, including GLP1 drugs like Wegovy and Mounjaro, are increasingly available though with restricted NHS eligibility. Health officials emphasize that pharmacological approaches must complement broader societal changes including dietary improvements, increased physical activity, and reduced promotion of unhealthy foods.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI